| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199612053352301 |
| P698 | PubMed publication ID | 8929262 |
| P2093 | author name string | Wallace A | |
| Mangano DT | |||
| Layug EL | |||
| Tateo I | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 1713-1720 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group | |
| P478 | volume | 335 |
| Q82093005 | 2-year survival with atenolol administration |
| Q34431980 | 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of A |
| Q47708045 | 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity |
| Q41720860 | A Therapeutic Commentary |
| Q34324204 | A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta-blockade: the EPIC study. |
| Q34987813 | A regional quality improvement effort to increase beta blocker administration before vascular surgery |
| Q58975358 | ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary |
| Q36494375 | ACC/AHA guidelines for preoperative cardiovascular evaluation for noncardiac surgery: a critical point of view. |
| Q43186548 | About fACE: perioperative use of angiotensin-converting enzyme inhibitors |
| Q39444649 | Acute ischemic syndromes following coronary artery bypass graft surgery. |
| Q36595236 | Acute peri-operative beta blockade in intermediate-risk patients |
| Q35790295 | Advances in nuclear cardiology: preoperative risk stratification |
| Q36046070 | Advances in nuclear imaging for preoperative risk assessment |
| Q46284933 | Adverse effects of beta adrenergic blockers during spinal anesthesia with 0.5% bupivacaine |
| Q49713755 | Age Does Not Affect Metoprolol's Effect on Perioperative Outcomes (From the POISE Database). |
| Q48630974 | Age and sex-related differences in dose-dependent hemodynamic response to landiolol hydrochloride during general anesthesia |
| Q28166554 | Alabama coronary artery bypass grafting project: results from phase II of a statewide quality improvement initiative |
| Q24250088 | Alpha-2 adrenergic agonists for the prevention of cardiovascular complications among patients undergoing cardiac or non-cardiac surgery |
| Q44493115 | Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis |
| Q42917559 | Alpha-2 agonists to reduce vasopressor requirements in septic shock? |
| Q73870580 | An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery |
| Q35373386 | An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation. |
| Q34467423 | Anaesthesia and the cardiac patient: the patient versus the procedure |
| Q42165680 | Analgesia and sedation in intensive care medicine |
| Q43509250 | Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population. |
| Q37061532 | Anesthetic and perioperative management of intestinal and multivisceral allograft recipient in nontransplant surgery |
| Q37132526 | Anesthetic considerations in the patient with valvular heart disease undergoing noncardiac surgery |
| Q40859507 | Anesthetic management and perioperative surveillance |
| Q73383418 | Anti-ischemic properties of calcium-channel blockers: lessons from cardiac surgery |
| Q36988880 | Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? |
| Q73589268 | Assessing and reducing cardiac risks of noncardiac surgery |
| Q34743498 | Assessment and reporting of perioperative cardiac risk by Canadian general internists: art or science? |
| Q30479396 | Assessment of cardiac risk before non-cardiac general surgery |
| Q73782362 | Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients |
| Q41611523 | Assessment of operative risk for patients with advanced lung disease |
| Q46072498 | Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay |
| Q46445777 | Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients |
| Q33997246 | Autonomic and cardiovascular function in the geriatric patient |
| Q81589206 | Barriers to implementing a surgical beta-blocker protocol |
| Q37710941 | Benefits and risks associated with beta-blocker prophylaxis in noncardiac surgery. |
| Q42912203 | Beta blockade: the right time, the right dose, the right receptor! |
| Q42741918 | Beta blockers and statins in non-cardiac surgery |
| Q34089757 | Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study |
| Q42582620 | Beta blockers for patients at risk of cardiac events during non-cardiac surgery |
| Q33384734 | Beta blockers in non-cardiac surgery: haemodynamic data needed |
| Q37799500 | Beta-Adrenergic Blockade and Traumatic Brain Injury: Protective? |
| Q24243256 | Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery |
| Q24186611 | Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery |
| Q44170864 | Beta-blockade and growth hormone after burn |
| Q36480100 | Beta-blockade in the perioperative period: where do we stand after all the trials? |
| Q38687689 | Beta-blocker subtype and risks of perioperative adverse events following non-cardiac surgery: a nationwide cohort study |
| Q37199663 | Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD. |
| Q37082599 | Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions |
| Q34308923 | Betablocker treatment in diabetes mellitus |
| Q34746034 | Cardiac arrhythmias in cardiothoracic surgery |
| Q35152991 | Cardiac complications after elective major vascular surgery |
| Q46664344 | Cardiac disease in the non-cardiac surgical population: effect on survival |
| Q38071617 | Cardiac risk assessment before non-cardiac surgery |
| Q44576641 | Cardiac testing for noncardiac surgery: past, present, and future |
| Q46511312 | Cardiopulmonary bypass alters the pharmacokinetics of propranolol in patients undergoing cardiac surgery. |
| Q24245649 | Cardioselective beta-blockers for chronic obstructive pulmonary disease |
| Q34699281 | Cardioselective beta-blockers for chronic obstructive pulmonary disease. |
| Q51648717 | Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis. |
| Q34116299 | Cardioselective beta-blockers for reversible airway disease |
| Q81616832 | Cardiovascular risk assessment in cancer patients undergoing major surgery |
| Q36471572 | Changing risk of perioperative myocardial infarction |
| Q37592881 | Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies |
| Q52243500 | Clinical determinants in perioperative cardiac evaluation. |
| Q24801983 | Clinical review: Evidence-based perioperative medicine? |
| Q24800790 | Clinical review: how to optimize management of high-risk surgical patients |
| Q46729177 | Clinical role and efficacy of landiolol in the intensive care unit |
| Q39177907 | Clinical utility of sympathetic blockade in cardiovascular disease management |
| Q35158854 | Co-medications, pre-medication and common diseases in the elderly |
| Q36955252 | Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression |
| Q28241758 | Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone |
| Q35975712 | Complications of major aortic and lower extremity vascular surgery |
| Q42933502 | Computed Tomography and Scintigraphy vs. Cardiac Catheterization for Coronary Disease Screening Prior to Noncardiac Surgery |
| Q74589348 | Con: All patients should not receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery |
| Q30667288 | Contemporary management of chronic stable angina |
| Q46757234 | Continuous beta-block with esmolol in combination with enoximone: influence on cardiac function in high risk patients undergoing vascular surgery |
| Q40326191 | Controversies in perioperative medicine. |
| Q43206026 | Conversion of atrial flutter to sinus rhythm during landiolol infusion |
| Q33654004 | Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation |
| Q48805934 | Coronary artery angioplasty for treatment of peri-operative myocardial ischaemia |
| Q36084476 | Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient |
| Q52006554 | Critical appraisal of cardiac risk stratification before elective vascular surgery. |
| Q33814176 | Critical limb ischemia |
| Q37238150 | Critical limb ischemia: medical and surgical management |
| Q33690017 | Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing |
| Q42933146 | Current aspects of anesthetic management in urological patients |
| Q39392035 | Current treatment of chronic heart failure |
| Q35141098 | Current trends in preoperative patient evaluation and management for podiatric surgeons |
| Q46037191 | Derivation and Validation of a Geriatric-Sensitive Perioperative Cardiac Risk Index. |
| Q33621941 | Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity |
| Q41547528 | Does coronary revascularization before major vascular surgery decrease mortality? |
| Q87115213 | Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy? |
| Q44640295 | Early death following primary total hip arthroplasty: 1,727 procedures with mechanical thrombo-prophylaxis |
| Q41991214 | Effect of Perioperative β-Blockers on Pulmonary Complications among Patients with Chronic Obstructive Pulmonary Disease Undergoing Lung Resection Surgery |
| Q35003091 | Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature? |
| Q46008122 | Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol. |
| Q35773536 | Effect of chronic beta-blockade on peri-operative outcome in patients undergoing non-cardiac surgery: an analysis of observational and case control studies |
| Q46010968 | Effect of landiolol hydrochloride on suxamethonium-induced neuromuscular block. |
| Q34693219 | Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial |
| Q41971792 | Effect of pre-operative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists on intra-operative arterial pressures after induction of general anesthesia |
| Q36146266 | Effects of Glucose Concentration on Propofol Cardioprotection against Myocardial Ischemia Reperfusion Injury in Isolated Rat Hearts |
| Q97529789 | Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study |
| Q51033989 | Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. |
| Q34778589 | Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial |
| Q77983399 | Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: evidence of a protective effect of beta-blocking antianginal medications |
| Q38012515 | Endovascular aneurysm repair: a perioperative perspective |
| Q51375533 | Epidural infusion of bupivacaine and fentanyl reduces perioperative myocardial ischaemia in elderly patients with hip fracture--a randomized controlled trial. |
| Q42707836 | Essay for the CIHR/CMAJ award: impact of the Perioperative Ischemic Evaluation (POISE) trial |
| Q33710053 | Evidence at a glance: error matrix approach for overviewing available evidence |
| Q41712394 | Evidence based treatment of chronic stable angina |
| Q73580845 | Evidence-based perioperative risk reduction |
| Q32049357 | Evidence-based practice |
| Q36402666 | Exploring an optimum intra/postoperative management strategy for acute hypertension in the cardiac surgery patient |
| Q35158875 | Eye surgery in the elderly. |
| Q24542307 | From Cuthbertson to fast-track surgery: 70 years of progress in reducing stress in surgical patients |
| Q54131740 | Gaining control: can we reduce perioperative cardiovascular complications? |
| Q48368980 | General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent |
| Q35580952 | Genetic variation, β-blockers, and perioperative myocardial infarction |
| Q43284567 | Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery |
| Q22000596 | Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model |
| Q57245270 | Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca |
| Q51306994 | Heart rate increases linearly in response to acute isovolemic anemia. |
| Q35196105 | High oxygen partial pressure decreases anemia-induced heart rate increase equivalent to transfusion. |
| Q73560122 | Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction |
| Q35804504 | How low is too low? Cardiac risks with anemia |
| Q36183773 | How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials |
| Q34156178 | How to use evidence-based medicine in anaesthesiology |
| Q35738465 | Hypertension and the vascular patient |
| Q48893357 | Ideal peri-operative management of patients with cardiovascular disease: the quest continues |
| Q35969951 | Identifying high-risk patients undergoing urgent and emergency surgery |
| Q40386821 | Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study |
| Q36297514 | Improving the quality of care in bariatric surgery: the volume and outcome relationship |
| Q42583516 | In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic |
| Q43166412 | Incidence and prediction of major cardiovascular complications in head and neck surgery |
| Q33987122 | Increases in serum concentrations of cardiac proteins and the prediction of early postoperative cardiovascular complications in noncardiac surgery patients |
| Q30502980 | Inflammatory bowel disease: perioperative pharmacological considerations |
| Q44456108 | Interleukin balance and early recovery from anesthesia in elderly surgical patients exposed to beta-adrenergic antagonism |
| Q33786423 | Is simple clinical assessment adequate for cardiac risk stratification before elective non-cardiac surgery? |
| Q43988545 | Isoflurane-induced preconditioning is attenuated by diabetes |
| Q34767502 | Issues in the perioperative management of the elderly patient with cardiovascular disease |
| Q38052022 | Ivabradine: potential clinical applications in critically ill patients |
| Q93646494 | JournalScan |
| Q56624513 | Klinischer Einsatz von Beta-Blockern bei kardiovaskulären Indikationen: Neue Therapiestudien |
| Q35901380 | Lack of adherence with preoperative B-blocker recommendations in a multicenter study |
| Q46244433 | Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts |
| Q46852306 | Laparoscopic radical nephrectomy for suspected renal cell carcinoma in dialysis-dependent patients |
| Q24289034 | Learning from mistakes in clinical practice guidelines: the case of perioperative β-blockade |
| Q51411998 | Less adrenergic activation during cataract surgery with total intravenous than with local anesthesia. |
| Q48691758 | Lessons learned from a randomised controlled study of perioperative beta blockade in high risk patients undergoing emergency surgery |
| Q36422015 | Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. |
| Q87419333 | Major Cardiac Events After Non-cardiac Surgery |
| Q37978469 | Management of postoperative atrial fibrillation |
| Q36348923 | Managing patients undergoing non-cardiac surgery: need to shift emphasis from risk stratification to risk modification |
| Q34361033 | Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery |
| Q37153643 | Metabolic implications of severe burn injuries and their management: a systematic review of the literature |
| Q44606489 | Milrinone attenuates the negative inotropic effects of landiolol in halothane-anesthetized dogs |
| Q28166008 | Moderately elevated serum troponin concentrations are associated with increased morbidity and mortality rates in surgical intensive care unit patients |
| Q37178361 | Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs |
| Q36804924 | Multifactorial Model and Treatment Approaches of Refractory Hypotension in a Patient Who Took an ACE Inhibitor the Day of Surgery |
| Q34719574 | Multimodal strategies to improve surgical outcome |
| Q51355533 | Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. |
| Q35252659 | Myocardial infarction in major noncardiac surgery: Epidemiology, pathophysiology and prevention |
| Q34485184 | Myocardial ischemia. Monitoring to diagnose ischemia: how do I monitor therapy? |
| Q37680277 | Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft |
| Q52663462 | New-onset atrial fibrillation: an update. |
| Q33582173 | Non-cardiac surgery in developing countries: epidemiological aspects and economical opportunities--the case of Brazil |
| Q37944744 | Nutritional and Pharmacological Modulation of the Metabolic Response of Severely Burned Patients: Review of the Literature (Part II)* |
| Q47746910 | Optimal intraoperative haemodynamic management |
| Q41815997 | Optimal management of the high risk surgical patient: beta stimulation or beta blockade? |
| Q34261062 | Optimal perioperative management of arterial blood pressure. |
| Q37806694 | Optimizing the management of elderly colorectal surgery patients |
| Q56928570 | Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI) |
| Q48961875 | Patient safety and quality: can anaesthetists play a greater role? |
| Q51338670 | Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. |
| Q38107887 | Patients who require non-cardiac surgery in acute coronary syndrome |
| Q41343181 | Patterns of β-blocker initiation in patients undergoing intermediate to high-risk noncardiac surgery |
| Q35612101 | Peri-operative beta-blockade and haemodynamic optimisation in patients with coronary artery disease and decreasing exercise capacity presenting for major noncardiac surgery |
| Q38653570 | Peri-operative cardiac protection for non-cardiac surgery |
| Q51455912 | Peri-operative silent myocardial ischaemia in patients undergoing lower limb joint replacement surgery: an indicator of postoperative morbidity or mortality? |
| Q38179383 | Perioperative Beta blockade |
| Q47432764 | Perioperative and long-term prognostic value of dipyridamole Tc-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery |
| Q35577293 | Perioperative anesthesia issues in the elderly |
| Q37326885 | Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis |
| Q41733759 | Perioperative beta-blockade: might the baby go out with the bath water? |
| Q24250085 | Perioperative beta-blockers for preventing surgery related mortality and morbidity |
| Q24193541 | Perioperative beta-blockers for preventing surgery-related mortality and morbidity |
| Q90297209 | Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery |
| Q51740838 | Perioperative beta-blockers for preventing surgery-related mortality and morbidity. |
| Q34375129 | Perioperative cardiac complications |
| Q36642698 | Perioperative cardiac risk: pathophysiology, assessment and management |
| Q37956135 | Perioperative care for patients with rheumatic diseases |
| Q37311432 | Perioperative control of hypertension: when will it adversely affect perioperative outcome? |
| Q38213886 | Perioperative hypertensive emergencies |
| Q48571493 | Perioperative interventions to modify risk of morbidity and mortality |
| Q35599861 | Perioperative management and monitoring in anaesthesia |
| Q34516927 | Perioperative management of patients with connective tissue disease |
| Q34939631 | Perioperative management of the hospitalized patient |
| Q35151404 | Perioperative management of type 1 diabetes mellitus |
| Q41717876 | Perioperative medical considerations in patients with rheumatoid arthritis |
| Q37225189 | Perioperative medicine update |
| Q51394048 | Perioperative myocardial cell injury: the relationship between troponin T and cortisol. |
| Q36660628 | Perioperative myocardial infarction in non-cardiac surgery. Pathophysiology and clinical implications |
| Q34696254 | Perioperative myocardial infarction in noncardiac surgery: the diagnostic and prognostic role of cardiac troponins |
| Q93050608 | Perioperative myocardial injury and infarction following non-cardiac surgery: A review of the eclipsed epidemic |
| Q48906772 | Perioperative optimisation |
| Q24805141 | Perioperative risk stratification in non cardiac surgery: role of pharmacological stress echocardiography |
| Q42415622 | Perioperative use of beta-blockers |
| Q45015422 | Periprocedural hypertension: current concepts in management for the vascular surgeon |
| Q36879058 | Pharmacologic management of the older woman undergoing surgery |
| Q81075128 | Pharmacological prevention of cardiac risk in claudicants with ischaemic heart disease |
| Q38361941 | Pharmacological strategies for prevention of postoperative atrial fibrillation |
| Q33759396 | Pharmacological stress testing |
| Q24201062 | Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm |
| Q30239058 | Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm. |
| Q30448088 | Physiology and pharmacology of myocardial preconditioning and postconditioning |
| Q45102995 | Postoperative 12-lead ECG predicts peri-operative myocardial ischaemia associated with myocardial cell damage |
| Q35795665 | Postoperative care of vascular surgery patients |
| Q36552085 | Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients? |
| Q35559410 | Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study |
| Q44456176 | Prediction of major adverse cardiac events in vascular surgery: are cardiac risk scores of any practical value? |
| Q80335911 | Predictors of cardiovascular events and associated mortality within two years of kidney transplantation |
| Q37381635 | Preoperative Cardiac Evaluation and Management of the Patient Undergoing Major Vascular Surgery |
| Q48896959 | Preoperative assessment |
| Q37799111 | Preoperative assessment of cardiac risk and perioperative cardiac management in noncardiac surgery |
| Q34311317 | Preoperative cardiac assessment of the candidate for major resective pancreatic surgery |
| Q35756545 | Preoperative cardiac evaluation |
| Q48879032 | Preoperative cardiac evaluation |
| Q37992531 | Preoperative cardiac evaluation of the vascular surgery patient--an anesthesia perspective |
| Q37005494 | Preoperative cardiac testing before major vascular surgery |
| Q94467409 | Preoperative evaluation and treatment of stable CAD in patients scheduled for major elective vascular surgery |
| Q36963003 | Preoperative evaluation of a patient for abdominal aortic aneurysm repair. |
| Q48795458 | Preoperative evaluation of cardiac risk |
| Q35063123 | Preoperative risk evaluation and perioperative management of patients with coronary artery disease |
| Q80826821 | Preoperative risk evaluation in heart failure |
| Q40792445 | Preoperative β-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful |
| Q37472056 | Prevention of acute coronary events in noncardiac surgery: beta-blocker therapy and coronary revascularization |
| Q51529732 | Prevention of perioperative myocardial ischaemia and its complications. |
| Q57943255 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial |
| Q38226382 | Primer on outcomes research |
| Q36185658 | Principles of anaesthesia in urological surgery |
| Q33609554 | Pro: All elective coronary artery bypass grafting patients are American Society of Anesthesiologists' Physical Status IV. |
| Q78195240 | Pro: beta-blockers should be used in all patients undergoing vascular surgery |
| Q37147314 | Prognostic factors for mortality among patients above the 6th decade undergoing non-cardiac surgery: cares--clinical assessment and research in elderly surgical patients |
| Q35537694 | Prophylactic beta-blockade to prevent myocardial infarction perioperatively in high-risk patients who undergo general surgical procedures. |
| Q45334808 | Prophylactic coronary artery revascularization for elective vascular surgery: study design. Veterans Affairs Cooperative Study Group on Coronary Artery Revascularization Prophylaxis for Elective Vascular Surgery |
| Q46097488 | Prophylaxis of perioperative cardiovascular morbidity and mortality |
| Q74623555 | Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery |
| Q26830182 | Quality-of-care framework in urological cancers: where do we stand? |
| Q38382733 | RETRACTED: Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients |
| Q33329880 | Recognition and management of preoperative risk |
| Q36221974 | Reducing risk of cardiovascular events in noncardiac surgery |
| Q42765157 | Reducing the risk of major elective surgery. Paper should have given details on causes of death |
| Q46303039 | Relation of surgeon and hospital volume to processes and outcomes of colorectal cancer surgery |
| Q33997252 | Respiratory function in the elderly |
| Q52920923 | Results from three municipal hospitals regarding radical cystectomy on elderly patients. |
| Q35667091 | Risk factors for cardiovascular complications following total joint replacement surgery |
| Q34576644 | Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial |
| Q37822725 | Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery |
| Q34026382 | Role of dobutamine stress echocardiography for preoperative cardiac risk assessment before major vascular surgery: a diagnostic tool comes of age. |
| Q73810352 | Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial |
| Q51510355 | ST segment changes following retinal surgery. |
| Q42759374 | Safer non-cardiac surgery for patients with coronary artery disease. Medical treatment should be optimised to improve outcome |
| Q42785607 | Safer non-cardiac surgery for patients with coronary artery disease. Preoperative aspirin does increase risk of perioperative bleeding |
| Q37830055 | Safety of perioperative β-blocker use: how do β-blockers compare in terms of side effects? |
| Q37800343 | Screening and management of pretransplant cardiovascular disease |
| Q39167276 | Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis. |
| Q35687065 | Sepsis-induced cardiomyopathy |
| Q22306384 | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure |
| Q36052982 | Silent myocardial ischemia: recent developments |
| Q56891565 | Slowing the heart saves lives: advantages of perioperative beta-blockade |
| Q45330535 | Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans |
| Q56893512 | Statin Use Is Associated with Reduced All-Cause Mortality after Endovascular Abdominal Aortic Aneurysm Repair |
| Q74534482 | Stopping and restarting medications in the perioperative period |
| Q37482199 | Strategies for managing perioperative hypertension |
| Q48944110 | Stress response and optimization of perioperative care |
| Q35796326 | Support of the metabolic response to burn injury |
| Q74540119 | Surgery-specific considerations in the cardiac patient undergoing noncardiac surgery |
| Q36269072 | Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review |
| Q47694686 | Takotsubo syndrome in hemodynamically unstable patients admitted to the intensive care unit - a retrospective study |
| Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
| Q42663907 | The clinical course of new-onset atrial fibrillation after elective aortic operations |
| Q43817697 | The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery |
| Q42939020 | The effects of carvedilol administration on cardiopulmonary resuscitation in a rat model of cardiac arrest induced by airway obstruction |
| Q36739881 | The evidence-based pathway for peri-operative management of open and robotically assisted laparoscopic radical prostatectomy |
| Q46530092 | The haemodynamic effects of propranolol and atenolol medication on dobutamine infusion in patients with coronary artery obstructive disease. |
| Q37181299 | The hypermetabolic response to burn injury and interventions to modify this response |
| Q48893297 | The management of patients with ischaemic heart disease undergoing non-cardiac elective surgery: a survey of Australian and New Zealand clinical practice |
| Q36942627 | The need to reform our assessment of evidence from clinical trials: a commentary |
| Q36366987 | The pharmacoeconomics of peri-operative beta-blocker therapy |
| Q35597060 | The potential contribution of stress systems to the transition to chronic whiplash-associated disorders |
| Q78861063 | The role of cardiac morbidity in short- and long-term mortality in injured older patients who survive initial resuscitation |
| Q44630310 | The role of myocardial revascularization preceding noncardiac surgery |
| Q39379758 | The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit |
| Q52243494 | The role of the cardiology consultant: putting it all together. |
| Q51436148 | The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. |
| Q34802852 | The theory and practice of bloodless surgery |
| Q36841534 | Therapy insight: prophylaxis, monitoring and treatment of perioperative myocardial ischemia with emphasis on urological surgery. |
| Q36677201 | Thrombotic and bleeding complications after orthopedic surgery. |
| Q47692794 | To beta-block or not? |
| Q34457821 | Transient post-operative atrial fibrillation predicts short and long term adverse events following CABG. |
| Q48848930 | Troponin T-values provide long-term prognosis in elderly patients undergoing non-cardiac surgery |
| Q36162987 | Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease |
| Q79359221 | Update in perioperative medicine |
| Q40279612 | Use of beta-blockade to prevent death after noncardiac surgery |
| Q35638083 | Use of beta-blockers in patients with COPD. |
| Q48132351 | Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: a single-centre cohort study in 51,701 consecutive patients. |
| Q59320923 | Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial i |
| Q45018890 | Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery. |
| Q44071313 | Usefulness of clinical risk markers and ischemic threshold to stratify risk in patients undergoing major noncardiac surgery |
| Q85076735 | Usefulness of tissue Doppler echocardiography to predict perioperative cardiac events in patients undergoing noncardiac surgery |
| Q43597388 | Using postoperative cardiac Troponin-I (cTi) levels to detect myocardial ischaemia in patients undergoing vascular surgery |
| Q74243415 | Vascular surgery |
| Q58920396 | Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation |
| Q41556867 | What cardiologists need to know about diabetes. |
| Q77586254 | What is new in nuclear medicine imaging? |
| Q77340207 | [Benefit-risk and monitoring modalities of different techniques and methods of postoperative analgesia] |
| Q45963999 | [Beta-blockers in patients undergoing noncardiac surgery: implications of the POISE study]. |
| Q82637184 | [Cardioprotection] |
| Q54491860 | [Cognitive functions and cerebral oxygenation of older patients after general and regional anaesthesia]. |
| Q87858949 | [Comments on: perioperative administration of clonidine or aspirin] |
| Q73714217 | [How to read a scientific paper. Committee for Clinical References of the French Anesthesia and Resuscitation Society] |
| Q79331079 | [Interactions between cardiovascular drugs and anesthesia and surgery] |
| Q81430075 | [Limitations of anesthesia. Risks and older patients in daily practice] |
| Q80201175 | [Perioperative administration of beta-blockers. Critical appraisal of recent meta-analyses] |
| Q84039945 | [Perioperative beta-receptor blockade. For and against] |
| Q79889653 | [Perioperative cardioprotection. Golden standard beta-blockade?] |
| Q82510855 | [Perioperative management of long-term medication] |
| Q46505424 | [Perioperative pharmacological myocardial protection. Systematic literature-based process optimization]. |
| Q77340235 | [Postoperative locoregional analgesia in the adult: epidural and peripheral techniques. Indications, adverse effects and monitoring] |
| Q73635987 | [Postoperative mortality a university Department of General Surgery: incidence of cardiac-related deaths] |
| Q80250449 | [Premedication visits. Economizing at the cost of the patient?] |
| Q81624117 | [Preoperative evaluation and perioperative management of patients with increased cardiovascular risk] |
| Q81471491 | [Strategies for perioperative sympatho-modulation] |
| Q38103516 | β-Adrenergic blockade in cardiovascular disease |
| Q37928128 | β-Adrenergic blockers |
| Q34247559 | β-blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program |
| Q59745898 | β-blocker therapy in non-cardiac surgery – Authors' reply |
| Q40945236 | β-blockers in critically ill patients: from physiology to clinical evidence. |
Search more.